Skip to main content
. 2021 Oct 5;8(6):4465–4483. doi: 10.1002/ehf2.13595

Figure 4.

Figure 4

Schematic representation of ST2 and sST2 and their involvement in fibrosis and hypertrophy. IL‐33, interleukin‐33; ST2, suppression of tumourigenicity; sST2, soluble suppression of tumourigenicity.